Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Weight Loss Drug Mounjaro Set To Launch In India By 2025 | Obesity | Health News | Fitness | N18V Diabetes Pill For Weight Loss
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-19
Eli Lilly, a leading US pharmaceutical company, is gearing up to launch its groundbreaking diabetes and obesity medication, Tirzepatide—commercially known as Mounjaro—in India by 2025. The drug has garnered widespread attention for its efficacy in addressing both type 2 diabetes and obesity. With marketing authorizations already secured, the company is now working through final regulatory approvals before introducing this innovative solution to the Indian market.
#weightloss #mounjaro #health #fitness #news18
News18 Mobile App -
Weight Loss Drug Mounjaro Set To Launch In India By 2025 | Obesity | Health News | Fitness | N18V For Country: United States. City: Murrieta, Oceanside, Palmdale, Wichita, Zion
Tag: #Diabetes Pill For Weight Loss, #over the counter ozempic alternatives, #how can i get on ozempic for weight loss, #pill k 25, #saxenda stock
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication